• Home
  • Contacts
  • FAQs
  • Careers

Mesoblast

  • About us
    • Company overview
    • Board of Directors
    • Corporate Governance
      • Role and Composition of the Board
      • Constitution
      • Board Committees and Charters
      • Shareholder Communication
      • Risk Management
      • Code of Conduct
      • Key Policies
    • Partners
  • Products
    • Cardiovascular diseases
    • Diabetes
    • Oncology
    • Eye disease products
    • Orthopedic Diseases
  • Technology
    • Overview
    • Scientific publications
      • Technology
      • Orthopedic
      • Cardiovascular
      • Neurological
  • Clinical trials
    • Overview
    • FAQs
  • Investors
    • Overview
    • Market announcements
    • Presentations
    • Analyst Coverage
    • Webcasts
    • Annual Reports
    • ADR trading
    • Email alerts
    • Shareholder meetings
    • Financial Tear Sheet
  • Newsroom
    • Market Announcements
      • Archives
    • Image downloads
    • Email alerts
    • Contacts

Orthopedic

March 2012 - Immunoselected STRO-3+ mesenchymal precursor cells and restoration of the extracellular matrix of degenerate intervertebral discs March 2012 - Immunoselected STRO-3+ mesenchymal precursor cells and restoration of the extracellular matrix of degenerate intervertebral discs
  • April 2011 - Cervical Interbody Fusion Is Enhanced by Allogeneic Mesenchymal Precursor Cells in an Ovine Model

  • April 2011 - A Comparison of Mesenchymal Precursor Cells and Amnion Epithelial Cells for Enhancing Cervical Interbody Fusion in an Ovine Model

  • June 2010 - Cervical motion preservation using mesenchymal progenitor cells and pentosan polysulfate, a novel chondrogenic agent: preliminary study in an ovine model

  • 31 March 2010 - Potential Applications for Using Stem Cells in Spine Surgery

  • 16 March 2010 - Pentosan polysulfate promotes proliferation and chondrogenic differentiation of adult human bone marrow-derived mesenchymal precursor cells

  • 2009 - Intra-articular Injection of Allogeneic Immunoselected STRO-3+ Mesenchymal Precursor Stem Cells into Ovine Joints with Pre-existing Osteoarthritis Improves Articular Cartilage Integrity 6 Month

  • Technology
    • Overview
    • Scientific publications
      • Technology
      • Orthopedic
      • Cardiovascular
      • Neurological

    Products

    The American Heart Association estimates 80 million American adults (approximately 1 in 3) have one or more forms of cardiovascular diseases...

    Find out more

    Technology

    Stem cell therapy is emerging as the new paradigm for treating and potentially curing human disease. It involves the use of living cells...

    Find out more

    Clinical trials

    Mesoblast is aiming to produce therapeutics for the treatment of heart conditions, blood vessel diseases of the eyes and legs bone marrow regeneration after cancer...

    Find out more
    • Privacy policy
    • Disclaimer
    • Webmail
    • Sitemap
    Copyright © 2013 Mesoblast | Website design by Mightymedia